Sage Therapeutics, Inc. 4
4 · Sage Therapeutics, Inc. · Filed Jun 8, 2015
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Sale
Common Stock
2015-06-08$79.95/sh−4,300$343,785→ 7,200 total - Sale
Common Stock
2015-06-08$78.56/sh−1,200$94,272→ 6,000 total - Exercise/Conversion
Stock Options (Right to buy)
2015-06-08−5,500→ 132,169 totalExercise: $8.92Exp: 2024-05-21→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2015-06-08$8.92/sh+5,500$49,060→ 11,500 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $79.15 USD to $80.09 USD. The price reported above reflects the weighted average sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $78.26 USD to $78.96 USD. The price reported above reflects the weighted average sale price.
- [F4]The option, representing a right to purchase a total of 137,669 shares, became partially exercisable beginning on May 05, 2015. 25% of this option vested on May 05, 2015 and the remainder vests in equal monthly installments thereafter over 36 months.